197 related articles for article (PubMed ID: 24485974)
21. A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE.
Chaléat-Valayer E; Parratte B; Colin C; Denis A; Oudin S; Bérard C; Bernard JC; Bourg V; Deleplanque B; Dulieu I; Evrard P; Filipetti P; Flurin V; Gallien P; Héron-Long B; Hodgkinson I; Husson I; Jaisson-Hot I; Maupas E; Meurin F; Monnier G; Pérennou D; Pialoux B; Quentin V; Moreau MS; Schneider M; Yelnik A; Marque P
Eur J Paediatr Neurol; 2011 Sep; 15(5):439-48. PubMed ID: 21745754
[TBL] [Abstract][Full Text] [Related]
22. Acute Management of Paradoxical Vocal Fold Motion (Vocal Cord Dysfunction).
Denipah N; Dominguez CM; Kraai EP; Kraai TL; Leos P; Braude D
Ann Emerg Med; 2017 Jan; 69(1):18-23. PubMed ID: 27522309
[TBL] [Abstract][Full Text] [Related]
23. Association of breathing sound spectra with glottal dimensions in exercise-induced vocal cord dysfunction.
Geneid A; Aaltonen LM; Porra L; Peltonen J; Palmu K; Sovijärvi A; Piirilä P
Eur Arch Otorhinolaryngol; 2017 Nov; 274(11):3933-3940. PubMed ID: 28852841
[TBL] [Abstract][Full Text] [Related]
24. Botulinum toxin type A in children and adolescents with severe cerebral palsy: a retrospective chart review.
Mesterman R; Gorter JW; Harvey A; Lockhart J; McEwen-Hill J; Margallo K; Goldie N
J Child Neurol; 2014 Feb; 29(2):210-3. PubMed ID: 23965398
[TBL] [Abstract][Full Text] [Related]
25. Vocal cord dysfunction related to water-damaged buildings.
Cummings KJ; Fink JN; Vasudev M; Piacitelli C; Kreiss K
J Allergy Clin Immunol Pract; 2013 Jan; 1(1):46-50. PubMed ID: 24229821
[TBL] [Abstract][Full Text] [Related]
26. Effects of different dilutions of botulinum toxin type A treatment for children with cerebral palsy with spastic ankle plantarflexor: a randomized controlled trial.
Lee JH; Sung IY; Yoo JY; Park EH; Park SR
J Rehabil Med; 2009 Sep; 41(9):740-5. PubMed ID: 19774308
[TBL] [Abstract][Full Text] [Related]
27. Long lasting benefits following the combination of static night upper extremity splinting with botulinum toxin A injections in cerebral palsy children.
Kanellopoulos AD; Mavrogenis AF; Mitsiokapa EA; Panagopoulos D; Skouteli H; Vrettos SG; Tzanos G; Papagelopoulos PJ
Eur J Phys Rehabil Med; 2009 Dec; 45(4):501-6. PubMed ID: 20032908
[TBL] [Abstract][Full Text] [Related]
28. Cricopharyngeal achalasia in children: botulinum toxin injection as a tool for diagnosis and treatment.
Scholes MA; McEvoy T; Mousa H; Wiet GJ
Laryngoscope; 2014 Jun; 124(6):1475-80. PubMed ID: 24122834
[TBL] [Abstract][Full Text] [Related]
29. Working Towards a Common Transatlantic Approach for Evaluation of Exercise-Induced Laryngeal Obstruction.
Røksund OD; Olin JT; Halvorsen T
Immunol Allergy Clin North Am; 2018 May; 38(2):281-292. PubMed ID: 29631736
[TBL] [Abstract][Full Text] [Related]
30. Botulinum toxin type A on oral health in treating sialorrhea in children with cerebral palsy: a randomized, double-blind, placebo-controlled study.
Wu KP; Ke JY; Chen CY; Chen CL; Chou MY; Pei YC
J Child Neurol; 2011 Jul; 26(7):838-43. PubMed ID: 21551374
[TBL] [Abstract][Full Text] [Related]
31. Is injection of botulinum toxin type A effective in the treatment of drooling in children with cerebral palsy?
Vaile L; Finlay F
Arch Dis Child; 2006 Oct; 91(10):862-3. PubMed ID: 16990361
[No Abstract] [Full Text] [Related]
32. Botulinum neurotoxin A: an unusual systemic effect.
Howell K; Selber P; Graham HK; Reddihough D
J Paediatr Child Health; 2007 Jun; 43(6):499-501. PubMed ID: 17535186
[TBL] [Abstract][Full Text] [Related]
33. Asthma: vocal cord dysfunction (VCD) and other dysfunctional breathing disorders.
Balkissoon R; Kenn K
Semin Respir Crit Care Med; 2012 Dec; 33(6):595-605. PubMed ID: 23047311
[TBL] [Abstract][Full Text] [Related]
34. Paradoxical vocal fold motion: presentation and treatment options.
Altman KW; Mirza N; Ruiz C; Sataloff RT
J Voice; 2000 Mar; 14(1):99-103. PubMed ID: 10764121
[TBL] [Abstract][Full Text] [Related]
35. Airway obstruction in children with cerebral palsy: need for tracheostomy?
Kontorinis G; Thevasagayam MS; Bateman ND
Int J Pediatr Otorhinolaryngol; 2013 Oct; 77(10):1647-50. PubMed ID: 23947996
[TBL] [Abstract][Full Text] [Related]
36. Use of POCUS in the Diagnosis of Paradoxical Vocal Cord Movement.
Wiltrakis SM; Gutierrez P
Pediatr Emerg Care; 2022 Mar; 38(3):e1085-e1086. PubMed ID: 35226635
[TBL] [Abstract][Full Text] [Related]
37. [The use of botulinum toxin in the treatment of spastic hip joint instability in children with cerebral palsy].
Jóźwiak M; Harasymczuk P; Ciemniewska-Gorzela K
Chir Narzadow Ruchu Ortop Pol; 2007; 72(3):205-9. PubMed ID: 17941584
[TBL] [Abstract][Full Text] [Related]
38. Functional outcomes of multilevel botulinum toxin and comprehensive rehabilitation in cerebral palsy.
Balbaloglu O; Basaran A; Ayoglu H
J Child Neurol; 2011 Apr; 26(4):482-7. PubMed ID: 21270468
[TBL] [Abstract][Full Text] [Related]
39. Question 2: is there any long-term benefit from injecting botulinum toxin-A into children with cerebral palsy?
Bradley LJ; Huntley JS
Arch Dis Child; 2014 Apr; 99(4):392-4. PubMed ID: 24626322
[No Abstract] [Full Text] [Related]
40. Can we identify predictors of multilevel botulinum toxin A injections in children with cerebral palsy who walk with a flexed knee pattern?
Scholtes VA; Dallmeijer AJ; Becher JG
J Child Neurol; 2008 Jun; 23(6):628-34. PubMed ID: 18281620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
